Evidence map›Paper›PMID 19772837›Full record

ReviewDiscovery medicine2009

An emerging role for Ubiquilin 1 in regulating protein quality control system and in disease pathogenesis.

Can Zhang, Aleister J Saunders

Abstract readReview
In one paragraph

Review in Discovery medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. GABAInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Combating deleterious phase transitions in neurodegenerative disease.Biochimica et biophysica acta. Molecular cell research · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Ubiquilin-1 protects cells from oxidative stress and ischemic stroke caused tissue injury in mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Can ZhangMassachusetts General Hospital/Harvard Medical School, MA, USA.
Aleister J Saunders
Massachusetts General Hospital · US

Funding

Identification and Characterization of APP Metabolism RegulatorsR01NS057295 · NINDS · DREXEL UNIVERSITY · PI SAUNDERS, ALEISTER J. · 2008 to 2012
$1.6M
NINDS NIH HHS R01 NS057295
6 · The paper itself

Abstract

The process of refolding or degrading misfolded proteins is the most important function of protein quality control (PQC) system. An imbalance between the capacity of PQC system and the quantity and severity of misfolded proteins may result in protein aggregate accumulation, which can ultimately contribute to a class of diseases referred to as conformational disorders. Numerous lines of evidence suggest that Ubiquilin 1 is an important component in PQC. Ubiquilin 1 has been indicated to be involved in the pathophysiology of neurodegenerative diseases and cancer. Here we review the evidence that Ubiquilin 1 is an important component of the PQC system and also review the role of Ubiquilin 1 in human diseases.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsHumansNeoplasmsNeurodegenerative DiseasesProtein FoldingProteinsUbiquitinsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsProteinsUbiquitinsUBQLN1 protein, human

Identifiers

PMID19772837
PMCPMC3158983
OpenAlexW1581471995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.